Regeneration of Infarcted Myocardium with Resveratrol-modified Cardiac Stem Cells

Overview

Journal J Cell Mol Med

Specialties Cell Biology
Molecular Biology

Date 2011 Mar 1

PMID 21352470

Citations 30

Authors

Nikolai Gorbunov

Goran Petrovski

Narasimman Gurusamy

Diptarka Ray

Do Han Kim

Dipak K Das

Affiliations

Soon will be listed here.

Abstract

The major problem in stem cell therapy includes viability and engraftment efficacy of stem cells after transplantation. Indeed, the vast majority of host-transfused cells do not survive beyond 24-72 hrs. To increase the survival and engraftment of implanted cardiac stem cells in the host, we developed a technique of treating these cells with resveratrol, and tested it in a rat model of left anterior descending (LAD) occlusion. Multi-potent clonogenic cardiac stem cells isolated from rat heart and stably transfected with EGFP were pre-treated with 2.5 μM resveratrol for 60 min. Rats were anaesthetized, hearts opened and the LAD occluded to induce heart attack. One week later, the cardiac reduced environment was confirmed in resveratrol treated rat hearts by the enhanced expression of nuclear factor-E2-related factor-2 (Nrf2) and redox effector factor-1 (Ref-1). M-mode echocardiography after stem cell therapy, showed improvement in cardiac function (left ventricular ejection fraction, fractional shortening and cardiac output) in both, the treated and control group after 7 days, but only resveratrol-modified stem cell group revealed improvement in cardiac function at the end of 1, 2 and 4 months time. The improvement of cardiac function was accompanied by enhanced stem cell survival and engraftment as demonstrated by the expression of cell proliferation marker Ki67 and differentiation of stem cells towards the regeneration of the myocardium as demonstrated by the expression of EGFP up to 4 months after LAD occlusion in the resveratrol-treated stem cell group. Expression of stromal cell-derived factor and myosin conclusively demonstrated homing of stem cells in the infarcted myocardium, its regeneration leading to improvement of cardiac function.

Citing Articles

Mesenchymal stromal cells for the treatment of Alzheimer's disease: Strategies and limitations.

Regmi S, Liu D, Shen M, Kevadiya B, Ganguly A, Primavera R Front Mol Neurosci. 2022; 15:1011225.

PMID: 36277497 PMC: 9584646. DOI: 10.3389/fnmol.2022.1011225.

Friend or Foe: Xenobiotic Activation of Nrf2 in Disease Control and Cardioprotection.

Hedrich W, Wang H Pharm Res. 2021; 38(2):213-241.

PMID: 33619640 DOI: 10.1007/s11095-021-02997-y.

The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.

Carresi C, Scicchitano M, Scarano F, Macri R, Bosco F, Nucera S Nutrients. 2021; 13(1).

PMID: 33477916 PMC: 7833367. DOI: 10.3390/nu13010275.

Stem Cell Metabolism: Powering Cell-Based Therapeutics.

Rigaud V, Hoy R, Mohsin S, Khan M Cells. 2020; 9(11).

PMID: 33207756 PMC: 7696341. DOI: 10.3390/cells9112490.

Resveratrol rescues TNF‑α‑induced inhibition of osteogenesis in human periodontal ligament stem cells via the ERK1/2 pathway.

Yuan J, Wang X, Ma D, Gao H, Zheng D, Zhang J Mol Med Rep. 2020; 21(5):2085-2094.

PMID: 32186753 PMC: 7115248. DOI: 10.3892/mmr.2020.11021.

References

Das D, Mukherjee S, Ray D . Resveratrol and red wine, healthy heart and longevity. Heart Fail Rev. 2010; 15(5):467-77. DOI: 10.1007/s10741-010-9163-9. View

Bertelli A, Das D . Grapes, wines, resveratrol, and heart health. J Cardiovasc Pharmacol. 2009; 54(6):468-76. DOI: 10.1097/FJC.0b013e3181bfaff3. View

Das M, Das D . Resveratrol and cardiovascular health. Mol Aspects Med. 2010; 31(6):503-12. DOI: 10.1016/j.mam.2010.09.001. View

Wang Z, Zhang F, Wang L, Yao Y, Zhao Q, Gao X . Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol Int. 2009; 33(6):665-74. DOI: 10.1016/j.cellbi.2009.03.006. View

Malik G, Gorbounov N, Das S, Gurusamy N, Otani H, Maulik N . Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Antioxid Redox Signal. 2006; 8(11-12):2101-9. DOI: 10.1089/ars.2006.8.2101. View

Yousef M, Schannwell C, Kostering M, Zeus T, Brehm M, Strauer B . The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol. 2009; 53(24):2262-9. DOI: 10.1016/j.jacc.2009.02.051. View

Abdel-Latif A, Bolli R, Tleyjeh I, Montori V, Perin E, Hornung C . Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167(10):989-97. DOI: 10.1001/archinte.167.10.989. View

Laflamme M, Gold J, Xu C, Hassanipour M, Rosler E, Police S . Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol. 2005; 167(3):663-71. PMC: 1698736. DOI: 10.1016/S0002-9440(10)62041-X. View

Cottage C, Bailey B, Fischer K, Avitabile D, Avitable D, Collins B . Cardiac progenitor cell cycling stimulated by pim-1 kinase. Circ Res. 2010; 106(5):891-901. PMC: 3116713. DOI: 10.1161/CIRCRESAHA.109.208629. View

10.

Das D, Maulik N . Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006; 6(1):36-47. DOI: 10.1124/mi.6.1.7. View

11.

Zeng B, Chen H, Zhu C, Ren X, Lin G, Cao F . Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac Surg. 2008; 34(4):850-6. DOI: 10.1016/j.ejcts.2008.05.049. View

12.

Li W, Ma N, Ong L, Nesselmann C, Klopsch C, Ladilov Y . Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007; 25(8):2118-27. DOI: 10.1634/stemcells.2006-0771. View

13.

Klopsch C, Furlani D, Gabel R, Li W, Pittermann E, Ugurlucan M . Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med. 2009; 13(4):664-79. PMC: 3822874. DOI: 10.1111/j.1582-4934.2008.00546.x. View

14.

Das S, Khan N, Mukherjee S, Bagchi D, Gurusamy N, Swartz H . Redox regulation of resveratrol-mediated switching of death signal into survival signal. Free Radic Biol Med. 2007; 44(1):82-90. DOI: 10.1016/j.freeradbiomed.2007.09.008. View

15.

Tritto I, Ambrosio G . Role of oxidants in the signaling pathway of preconditioning. Antioxid Redox Signal. 2001; 3(1):3-10. DOI: 10.1089/152308601750100425. View

16.

Beltrami A, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S . Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114(6):763-76. DOI: 10.1016/s0092-8674(03)00687-1. View

17.

Lekli I, Gurusamy N, Ray D, Tosaki A, Das D . Redox regulation of stem cell mobilization. Can J Physiol Pharmacol. 2009; 87(12):989-95. DOI: 10.1139/Y09-102. View

18.

Gurusamy N, Mukherjee S, Lekli I, Bearzi C, Bardelli S, Das D . Inhibition of ref-1 stimulates the production of reactive oxygen species and induces differentiation in adult cardiac stem cells. Antioxid Redox Signal. 2008; 11(3):589-600. PMC: 2933566. DOI: 10.1089/ars.2008.2195. View

19.

Gurusamy N, Ray D, Lekli I, Das D . Red wine antioxidant resveratrol-modified cardiac stem cells regenerate infarcted myocardium. J Cell Mol Med. 2010; 14(9):2235-9. PMC: 3822562. DOI: 10.1111/j.1582-4934.2010.01140.x. View

20.

Cook S, Matsui T, Li L, Rosenzweig A . Transcriptional effects of chronic Akt activation in the heart. J Biol Chem. 2002; 277(25):22528-33. DOI: 10.1074/jbc.M201462200. View